Adline Chem Lab's Q1 FY25 Financial Report Shows Decline, Receives 'Strong Sell' Rating

Jul 15 2024 09:00 PM IST
share
Share Via
Adline Chem Lab, a microcap pharmaceutical company, has reported a flat performance for the quarter ending June 2024, with a score of -3 compared to 0 in the previous quarter. The company's operating profit and profit before tax were at their lowest in the last five quarters, while the earnings per share also showed a declining trend. With a 'Strong Sell' rating from MarketsMojo, investors may want to reconsider their investment in the company.

Adline Chem Lab, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Strong Sell’ rating by MarketsMOJO, indicating a negative outlook for investors.

According to the financial report, Adline Chem Lab’s performance for the quarter has been flat, with a score of -3 compared to 0 in the previous quarter. This decline in score is a cause for concern for the company and its shareholders.


The company’s operating profit (PBDIT) for the quarter was at its lowest in the last five quarters, standing at Rs -0.10 crore. This indicates a negative trend in the near term for the company’s operating profit. Similarly, the profit before tax (PBT) less other income was also at its lowest in the last five quarters, standing at Rs -0.10 crore. This is another concerning factor for the company’s profitability.


The earnings per share (EPS) for the quarter was also at its lowest in the last five quarters, at Rs -0.17. This shows a declining trend in profitability and a lower return for shareholders.


Overall, Adline Chem Lab’s financial performance for the quarter ending June 2024 has not been positive. With a ‘Strong Sell’ rating from MarketsMOJO, investors may want to carefully consider their investment in the company.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News